Cited by 1,828Substance Abuse Treatment and OutcomesAlcohol Consumption and Health EffectsAlcoholism and Thiamine Deficiency

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Naltrexone in the Treatment of Alcohol Dependence

Volpicelli, Joseph R.·1992·Archives of General Psychiatry

DOI 10.1001/archpsyc.1992.01820110040006

Open this paper in CoChat — free account

Abstract

Seventy male alcohol-dependent patients participated in a 12-week, double-blind, placebo-controlled trial of naltrexone hydrochloride (50 mg/d) as an adjunct to treatment following alcohol detoxification. Subjects taking naltrexone reported significantly less alcohol craving and days in which any alcohol was consumed. During the 12-week study, only 23% of the naltrexone-treated subjects met the criteria for a relapse, whereas 54.3% of the placebo-treated subjects relapsed. The primary effect of naltrexone was seen in patients who drank any alcohol while attending outpatient treatment. Nineteen (95%) of the 20 placebo-treated patients relapsed after they sampled alcohol, while only eight (50%) of 16 naltrexone-treated patients exposed to alcohol met relapse criteria. Naltrexone was not associated with mood changes or other psychiatric symptoms. Significant side effects (nausea) occurred in two naltrexone-treated subjects, and one naltrexone-treated subject complained of increased pain from arthritis. These results suggest that naltrexone may be a safe and effective adjunct to treatment in alcohol-dependent subjects, particularly in preventing alcohol relapse.

Integrity signals

Registry

Crossref · 10.1001/archpsyc.1992.01820110040006

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The Hopkins Symptom Checklist (HSCL): A self-report symptom inventory
Derogatis, L. R., Lipman, R. S., Rickels, K., Uhlenhuth, E. H., & Covi, L. (1974) · Behavioral Science · doi:10.1002/bs.3830190102 · Cited by 4,604
Survival Analysis
Miller, R. G. (1981) · Cited by 3,336
Disulfiram treatment of alcoholism. A Veterans Administration cooperative study
Fuller, R. K. (1986) · JAMA · doi:10.1001/jama.256.11.1449 · Cited by 541
Alteration of ethanol self-administration by naltrexone
Altshuler, H. L., Phillips, P. E., & Feinhandler, D. A. (1980) · Life Sciences · doi:10.1016/0024-3205(80)90257-x · Cited by 397
The Effectiveness of Alcoholism Treatment
Miller, W. R., & Hester, R. K. (1986) · Springer eBooks · doi:10.1007/978-1-4613-2191-0_7 · Cited by 276
The serotonin uptake inhibitor citalopram attenuates ethanol intake
Naranjo, C. A., Sellers, E. M., Sullivan, J. T., Woodley-Remus, D., Kadlec, K. E., & Sykora, K. (1987) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1987.27 · Cited by 236
Naltrexone blocks the post-shock increase of ethanol consumption
Volpicelli, J. R., Davis, M. A., & Olgin, J. E. (1986) · Life Sciences · doi:10.1016/0024-3205(86)90601-6 · Cited by 187
Self-citation
Antagonism by naltrexone of voluntary alcohol selection in the chronically drinking macaque monkey
Myers, R. D., Borg, S., & Mossberg, R. (1986) · Alcohol · doi:10.1016/0741-8329(86)90058-3 · Cited by 167
Lithium Treatment of Depressed and Nondepressed Alcoholics
Dorus, W. (1989) · JAMA · doi:10.1001/jama.1989.03430120100029 · Cited by 164
Oral ethanol self-administration in the rat: Effect of naloxone
Samson, H. H., & Doyle, T. F. (1985) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(85)90491-5 · Cited by 162

Show all 23 references

Sorted by citations

Items 301–400 of 1,004

Alcohol and the brain
Nutt, D. (1999) · The British Journal of Psychiatry · doi:10.1192/bjp.175.2.114 · Cited by 104
Implication of the endogenous opioid system in excessive ethanol consumption
Gianoulakis, C., de Waele, J., & Thavundayil, J. (1996) · Alcohol · doi:10.1016/0741-8329(95)02035-7 · Cited by 103
Family History of Alcoholism Influences Naltrexone-Induced Reduction in Alcohol Drinking
Krishnan‐Sarin, S., Krystal, J. H., Shi, J. M., Pittman, B. P., & O’Malley, S. S. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.11.018 · Cited by 105
Spirituality-Based Recovery From Drug Addiction in the Twelve-Step Fellowship of Narcotics Anonymous
Galanter, M. S., Dermatis, H., Post, S. G., & Sampson, C. (2013) · Journal of Addiction Medicine · doi:10.1097/adm.0b013e31828a0265 · Cited by 101
Overview of Alcohol Use Disorder
Kranzler, H. R. (2023) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20230488 · Cited by 106
Ethanol-reinforced behaviour in the rat: effects of naltrexone
Bieńkowski, P., Kostowski, W., & Koroś, E. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00245-9 · Cited by 101
Naltrexone Alone and With Sertraline for the Treatment of Alcohol Dependence in Alaska Natives and Non‐Natives Residing in Rural Settings: A Randomized Controlled Trial
O’Malley, S. S., Robin, R. W., Levenson, A. L., GreyWolf, I., Chance, L. E., Hodgkinson, C. A., Romano, D. M., Robinson, J., Meandzija, B., Stillner, V., et al. (2008) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2008.00682.x · Cited by 102
Naltrexone for impulse control disorders in Parkinson disease
Papay, K., Xie, S. X., Stern, M., Hurtig, H. I., Siderowf, A. D., Duda, J. E., Minger, J., & Weintraub, D. A. (2014) · Neurology · doi:10.1212/wnl.0000000000000729 · Cited by 103
Prenatal exposure to ethanol increases ethanol consumption: a conditioned response?
Chotro, M. G., & Arias, C. (2003) · Alcohol · doi:10.1016/s0741-8329(03)00037-5 · Cited by 100
Gender differences with high-dose naltrexone in patients with co-occurring cocaine and alcohol dependence.
Pettinati, H., Kampman, K., Lynch, K., Suh, J. J., Dackis, C., Oslin, D., & O'Brien, C. (2008) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2007.05.011 · Cited by 96
Alcohol, the reward system and dependence
Koob, G. F., Rassnick, S., Heinrichs, S. C., & Weiss, F. (1994) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7330-7_11 · Cited by 98
[3H]Naloxone binding in the human brain: alcoholism and theTaqI A D2 dopamine receptor polymorphism
Ritchie, T. L., & Noble, E. P. (1996) · Brain Research · doi:10.1016/0006-8993(96)00068-6 · Cited by 100
Treatment of compulsive sexual behaviour with naltrexone and serotonin reuptake inhibitors: two case studies
Raymond, N. C., Grant, J. E., Kim, S. W., & Coleman, E. (2002) · International Clinical Psychopharmacology · doi:10.1097/00004850-200207000-00008 · Cited by 99
Modeling Relapse in Animals
Martin‐Fardon, R., & Weiss, F. (2012) · Current topics in behavioral neurosciences · doi:10.1007/7854_2012_202 · Cited by 105
A Double‐Blind, Placebo‐Controlled Study of Naltrexone in the Treatment of Alcohol‐Dependence Disorder: Results from a Multicenter Clinical Trial
Guardia, J., Caso, C., Árias, F., Gual, A., Sanahuja, J., Ramírez, M., Mengual, I., Gonzalvo, B., Segura, L., Trujols, J., et al. (2002) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2002.tb02682.x · Cited by 135
Naltrexone's effects on reactivity to alcohol cues among alcoholic men.
Rohsenow, D. J., Monti, P. M., Hutchison, K. E., Swift, R. M., Colby, S. M., & Kaplan, G. B. (2000) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.109.4.738 · Cited by 99
Addicted to Hair Pulling? How an Alternate Model of Trichotillomania May Improve Treatment Outcome
Grant, J. E., Odlaug, B. L., & Potenza, M. N. (2007) · Harvard Review of Psychiatry · doi:10.1080/10673220701298407 · Cited by 97
Naltrexone, smoking behaviour and cigarette withdrawal
Sutherland, G., Stapleton, J., Russell, M. A., & Feyerabend, C. (1995) · Psychopharmacology · doi:10.1007/bf02245813 · Cited by 98
Targeted Naltrexone for Early Problem Drinkers
Kranzler, H. R., Armeli, S., Tennen, H. A., Blomqvist, O., Oncken, C. A., Petry, N. M., & Feinn, R. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000084030.22282.6d · Cited by 97
Pharmacotherapies for Alcohol Problems: A Review of Research with Focus on Developments since 1991
Litten, R. Z., Allen, J., & Fertig, J. B. (1996) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1996.tb05264.x · Cited by 98
Effects of naltrexone on alcohol self‐administration and craving: meta‐analysis of human laboratory studies
Hendershot, C. S., Wardell, J. D., Samokhvalov, A. V., & Rehm, J. T. (2016) · Addiction Biology · doi:10.1111/adb.12425 · Cited by 96
Buprenorphine Reduces Alcohol Drinking Through Activation of the Nociceptin/Orphanin FQ-NOP Receptor System
Ciccocioppo, R., Economidou, D., Rimondini, R., Sommer, W. H., Massi, M., & Heilig, M. A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.01.006 · Cited by 96
The Role of Craving in Alcohol Use, Dependence, and Treatment
Flannery, B., Roberts, A. J., Cooney, N. L., Swift, R. M., Anton, R. F., & Rohsenow, D. J. (2001) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2001.tb02213.x · Cited by 96
Substance Abuse in Older People
Fingerhood, M. (2000) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2000.tb06900.x · Cited by 99
A systematic review of the effectiveness of naltrexone in the maintenance treatment of opioid and alcohol dependence
Roozen, H. G., de Waart, R., van der Windt, D., van den Brink, W., de Jong, C. A. J., & Kerkhof, A. J. F. M. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.11.001 · Cited by 97
The Gap Between Research and Practice in Substance Abuse Treatment
Marinelli‐Casey, P., Domier, C. P., & Rawson, R. A. (2002) · Psychiatric Services · doi:10.1176/appi.ps.53.8.984 · Cited by 96
A Clinical Laboratory Paradigm for Evaluating Medication Effects on Alcohol Consumption: Naltrexone and Nalmefene
Drobes, D. J., Anton, R. F., Thomas, S. E., & Voronin, K. E. (2002) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300101 · Cited by 96
Reduced Drinking in Alcohol Dependence Treatment, What Is the Evidence?
Mann, K., Aubin, H.-J., & Witkiewitz, K. (2017) · European Addiction Research · doi:10.1159/000481348 · Cited by 93
Developing neuroscience-based treatments for alcohol addiction: A matter of choice?
Heilig, M. A., Augier, E., Pfarr, S., & Sommer, W. H. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0591-6 · Cited by 104
Involvement of Accumbal Glycine Receptors in the Regulation of Voluntary Ethanol Intake in the Rat
Molander, A., L??f, E., Stomberg, R., Ericson, M., & S�derpalm, B. (2005) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000150009.78622.e0 · Cited by 93
Measuring Craving: An Attempt to Connect Subjective Craving with Cue Reactivity
Ooteman, W., Koeter, M. W. J., Vserheul, R., Schippers, G. M., & van den Brink, W. (2006) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2006.00019.x · Cited by 94
Pharmacotherapy for Alcohol Use Disorder
Swift, R. M., & Aston, E. R. (2015) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000079 · Cited by 97
A Randomized, Double‐Blind, Placebo‐Controlled Pilot Study of Naltrexone in Outpatients With Bipolar Disorder and Alcohol Dependence
Brown, E. S., Carmody, T. J., Schmitz, J. M., Caetano, R., Adinoff, B. H., Swann, A. C., & Rush, A. J. (2009) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2009.01024.x · Cited by 93
Increased P3 Amplitudes Induced by Alcohol‐Related Pictures in Patients With Alcohol Dependence
Namkoong, K., Lee, E. M., Lee, C. H., Lee, B. O., & An, S. K. (2004) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000139828.78099.69 · Cited by 93
Developing human laboratory models of smoking lapse behavior for medication screening
McKee, S. A. (2009) · Addiction Biology · doi:10.1111/j.1369-1600.2008.00135.x · Cited by 93
Behavioral Neurobiology of Alcohol Addiction
Sommer, W. H., & Spanagel, R. (2012) · Current topics in behavioral neurosciences · doi:10.1007/978-3-642-28720-6 · Cited by 93
Nalmefene Causes Greater Hypothalamic‐Pituitary‐Adrenal Axis Activation than Naloxone in Normal Volunteers: Implications for the Treatment of Alcoholism
Schluger, J. H., Ho, A., Borg, L., Porter, M., Maniar, S., Gunduz, M., Perret, G., King, A. C., & Kreek, M. J. (1998) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1998.tb03931.x · Cited by 93
Naltrexone treatment of comorbid alcohol and cocaine use disorders
Hersh, D., Kirk, J. R. V., & Kranzler, H. R. (1998) · Psychopharmacology · doi:10.1007/s002130050688 · Cited by 93
The impact of emotional stress early in life on adult voluntary ethanol intake-results of maternal separation in rats
Roman, E., & Nylander, I. (2005) · Stress · doi:10.1080/10253890500188666 · Cited by 94
Neuroanatomical patterns of Fos-like immunoreactivity induced by a palatable meal and meal-paired environment in saline- and naltrexone-treated rats
Park, T. H., & Carr, K. D. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00719-7 · Cited by 92
The adoption of medications in substance abuse treatment: associations with organizational characteristics and technology clusters.
Knudsen, H. K., Ducharme, L. J., & Roman, P. (2007) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2006.08.013 · Cited by 92
Effects of naltrexone with nicotine replacement on smoking cue reactivity: preliminary results
Hutchison, K. E., Monti, P. M., Rohsenow, D. J., Swift, R. M., Colby, S. M., Gnys, M., NIAURA, R. S., & Sirota, A. D. (1999) · Psychopharmacology · doi:10.1007/s002130050872 · Cited by 92
The opioid system in alcohol and drug dependence: Family‐based association study
Xuei, X., Wetherill, L. F., Bierut, L. J., Dick, D. M., Nürnberger, J. I., Foroud, T., & Edenberg, H. J. (2007) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30531 · Cited by 92
Novel Uncompetitive N-Methyl-d-Aspartate (NMDA)-Receptor Antagonist MRZ 2/579 Suppresses Ethanol Intake in Long-Term Ethanol-Experienced Rats and Generalizes to Ethanol Cue in Drug Discrimination Procedure
Hölter, S. M., Danysz, W., & Spanagel, R. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35324-8 · Cited by 92
A mu opioid receptor gene polymorphism (A118G) and naltrexone treatment response in adherent Korean alcohol-dependent patients
Kim, S., Kim, C.-M., Choi, S., Jae, Y.-M., Lee, H.-G., Son, B., Kim, J., Choi, Y.-S., Kim, H.-O., Kim, S., et al. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1330-5 · Cited by 91
The Reinforcing Properties of Alcohol are Mediated by GABAA1 Receptors in the Ventral Pallidum
June, H. L., Foster, K. L., McKay, P. F., Seyoum, R., Woods, J. E., Harvey, S. C., Eiler, W. J. A., Grey, C., Carroll, M. R., McCane, S., et al. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300239 · Cited by 91
The contribution of electrophysiology to knowledge of the acute and chronic effects of ethanol
Little, H. J. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00040-6 · Cited by 89
Overdose after detoxification: A prospective study☆
Wines, J. D., Saitz, R., Horton, N. J., Lloyd-Travaglini, C. A., & Samet, J. H. (2007) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2006.12.019 · Cited by 90
CLINICAL PREDICTORS OF RESPONSE TO NALTREXONE IN ALCOHOLIC PATIENTS: WHO BENEFITS MOST FROM TREATMENT WITH NALTREXONE?
Rubio, G., Ponce, G., Rodríguez–Jiménez, R., Jiménez‐Arriero, M. Á., Hoenicka, J., & Palomo, T. (2005) · Alcohol and Alcoholism · doi:10.1093/alcalc/agh151 · Cited by 91
Alcoholism treatment in the United States. An overview.
Fuller, R. K., & Hiller-Sturmhöfel, S. (1999) · PubMed Central · Cited by 90
Posttreatment Results of Combining Naltrexone with Cognitive-Behavior Therapy for the Treatment of Alcoholism
Anton, R. F., Moak, D. H., Latham, P. K., Waid, L. R., Malcolm, R. J., Dias, J. K., & Roberts, J. S. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200102000-00013 · Cited by 90
Advances in the Pharmacological Treatment of Pathological Gambling
Grant, J. E., Kim, S. W., & Potenza, M. N. (2003) · Journal of Gambling Studies · doi:10.1023/a:1021227214142 · Cited by 88
Alcoholism Treatment After Liver Transplantation: Lessons Learned From a Clinical Trial That Failed
Weinrieb, R. M., Horn, D. H. A. V., McLellan, A. T., Alterman, A. I., Calarco, J. S., O’Brien, C. P., & Lucey, M. R. (2001) · Psychosomatics · doi:10.1176/appi.psy.42.2.110 · Cited by 89
Validity of the Obsessive Compulsive Drinking Scale (OCDS): Does Craving Predict Drinking Behavior?
Kranzler, H. R., Mulgrew, C. L., Modesto‐Lowe, V., & Burleson, J. A. (1999) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1999.tb04030.x · Cited by 89
Alcohol and Psychiatric Comorbidity
Cornelius, J. R., Bukstein, O. G., Salloum, I. M., & Clark, D. B. (2002) · Springer eBooks · doi:10.1007/0-306-47939-7_24 · Cited by 89
Effects of Naltrexone on the Subjective Response to Amphetamine in Healthy Volunteers
Jayaram‐Lindström, N., Wennberg, P., Hurd, Y. L., & Franck, J. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000144893.29987.e5 · Cited by 88
Psychotic Spectrum Disorders and Alcohol Abuse: A Review of Pharmacotherapeutic Strategies and a Report on the Effectiveness of Naltrexone and Disulfiram
Petrakis, I. L., Nich, C., & Ralevski, E. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbl010 · Cited by 87
Pathological Gambling and Alcohol Use Disorder
Grant, J. E., Kushner, M. G., Kim, S. W., & Kim, S. W. (2002) · Europe PMC (PubMed Central) · Cited by 88
Nociceptin/orphanin FQ presynaptically decreases GABAergic transmission and blocks the ethanol-induced increase of GABA release in central amygdala
Roberto, M., & Siggins, G. R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601899103 · Cited by 87
Combining Ondansetron and Naltrexone Effectively Treats Biologically Predisposed Alcoholics: From Hypotheses to Preliminary Clinical Evidence
Johnson, B. A., Ait‐Daoud, N., & Prihoda, T. J. (2000) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2000.tb02048.x · Cited by 88
A Placebo‐Controlled, Double‐Blind Study of Fluoxetine in Severe Alcohol Dependence: Adjunctive Pharmacotherapy During and After Inpatient Treatment
Kabel, D., & Petty, F. (1996) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1996.tb01686.x · Cited by 88
Efficacy of naltrexone in smoking cessation: A preliminary study and an examination of sex differences
King, A. C., de Wit, H., Riley, R., Cao, D., NIAURA, R. S., & Hatsukami, D. K. (2006) · Nicotine & Tobacco Research · doi:10.1080/14622200600789767 · Cited by 87
Endogenous Opioid Blockade and Impulsive Responding in Alcoholics and Healthy Controls
Mitchell, J., Tavares, V. C., Fields, H. L., D’Esposito, M., & Boettiger, C. A. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301226 · Cited by 89
Ethanol oral self-administration is increased in mutant mice with decreased β-endorphin expression1Published on the World Wide Web on 1 April 1999.1
Grisel, J. E., Mogil, J. S., Grahame, N. J., Rubinstein, M., Belknap, J. K., Crabbe, J. C., & Low, M. J. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01384-0 · Cited by 87
Naltrexone Alteration of Acute Smoking Response in Nicotine-Dependent Subjects
King, A. C., & Meyer, P. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00258-6 · Cited by 87
Opioid receptors: Some perspectives from early studies of their role in normal physiology, stress responsivity, and in specific addictive diseases
Kreek, M. J. (1996) · Neurochemical Research · doi:10.1007/bf02532387 · Cited by 87
Prognostic Factors in Buprenorphine- versus Methadone-Maintained Patients
Schottenfeld, R. S., Pakes, J., & Kosten, T. R. (1998) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199801000-00006 · Cited by 87
Naltrexone and Dysphoria: Fact or Myth?
Miotto, K. A., McCann, M., Basch, J., Rawson, R. A., & Ling, W. W. (2002) · American Journal on Addictions · doi:10.1080/10550490290087929 · Cited by 86
Beating the urge: Implications of research into substance-related desires
Kavanagh, D. J., Andrade, J., & May, J. (2004) · Addictive Behaviors · doi:10.1016/j.addbeh.2004.06.009 · Cited by 86
ALCOHOL DEPENDENCE: A COMMENTARY ON MECHANISMS
Hoffman, P. L., & Tabakoff, B. (1996) · Alcohol and Alcoholism · doi:10.1093/oxfordjournals.alcalc.a008159 · Cited by 86
The role of the opioid system in alcohol dependence
Nutt, D. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881113504017 · Cited by 87
Pharmacotherapy of alcoholism – an update on approved and off-label medications
Soyka, M., & Müller, C. A. (2017) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2017.1349098 · Cited by 97
The Measurement of Craving
Mezinskis, J. P., Honos‐Webb, L., Kropp, F. B., & Somoza, E. C. (2001) · Journal of Addictive Diseases · doi:10.1300/j069v20n03_07 · Cited by 90
The Nociceptin/Orphanin FQ Receptor Agonist Ro 64-6198 Reduces Alcohol Self-Administration and Prevents Relapse-Like Alcohol Drinking
Kuzmin, A. V., Kreek, M. J., Bakalkin, G. Y., & Liljequist, S. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301169 · Cited by 85
Targeted Naltrexone for Problem Drinkers
Kranzler, H. R., Tennen, H. A., Armeli, S., Chan, G., Covault, J., Arias, A. J., & Oncken, C. A. (2009) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181ac5213 · Cited by 85
Naltrexone: Not Just for Opioids Anymore
Sudakin, D. L. (2015) · Journal of Medical Toxicology · doi:10.1007/s13181-015-0512-x · Cited by 85
OPIOID ANTAGONISTS IN THE TREATMENT OF ALCOHOL DEPENDENCE: CLINICAL EFFICACY AND PREVENTION OF RELAPSE
O’Malley, S. S. (1996) · Alcohol and Alcoholism · doi:10.1093/oxfordjournals.alcalc.a008223 · Cited by 85
Pharmacological approaches to reducing craving in patients with alcohol use disorders
Haass-Koffler, C. L., Leggio, L., & Kenna, G. A. (2014) · CNS Drugs · doi:10.1007/s40263-014-0149-3 · Cited by 83
Quantitative electroencephalographic (qEEG) correlates of craving during virtual reality therapy in alcohol-dependent patients
Lee, S. H., Han, D. H., Oh, S., Lyoo, I. K., Lee, Y. S., Renshaw, P. F., & Lukas, S. E. (2009) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.08.014 · Cited by 84
Mu Opioid Receptor Antagonists: Recent Developments
Goodman, A. J., Bourdonnec, B. L., & Dolle, R. E. (2007) · ChemMedChem · doi:10.1002/cmdc.200700143 · Cited by 84
OPRM1 Asn40Asp Predicts Response to Naltrexone Treatment: A Haplotype‐Based Approach
Oroszi, G., Anton, R. F., O’Malley, S. S., Swift, R. M., Pettinati, H. M., Couper, D. J., Yuan, Q., & Goldman, D. A. (2008) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2008.00846.x · Cited by 87
COMBINED ACAMPROSATE AND NALTREXONE, WITH COGNITIVE BEHAVIOURAL THERAPY IS SUPERIOR TO EITHER MEDICATION ALONE FOR ALCOHOL ABSTINENCE: A SINGLE CENTRES' EXPERIENCE WITH PHARMACOTHERAPY
Feeney, G. F. X., Connor, J. P., Young, R. M., Tucker, J., & McPherson, A. (2006) · Alcohol and Alcoholism · doi:10.1093/alcalc/agl007 · Cited by 84
The Development of an Ethanol Model Using Social Insects I: Behavior Studies of the Honey Bee (Apis mellifera L.)
Abramson, C. I., Stone, S. M., Ortez, R. A., Luccardi, A., Vann, K. L., Hanig, K. D., & Rice, J. (2000) · Alcoholism Clinical and Experimental Research · doi:10.1097/00000374-200008000-00004 · Cited by 84
Extended-release naltrexone (XR-NTX) attenuates brain responses to alcohol cues in alcohol-dependent volunteers: a bold FMRI study
Lukas, S. E., Lowen, S. B., Lindsey, K. P., Conn, N., Tartarini, W., Rodolico, J., Mallya, G., Palmer, C., & Penetar, D. M. (2013) · NeuroImage · doi:10.1016/j.neuroimage.2013.03.055 · Cited by 83
Neurochemical mechanisms of alcohol withdrawal
Becker, H. C., & Mulholland, P. J. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-62619-6.00009-4 · Cited by 88
The effect of methadone maintenance treatment on alcohol consumption: A systematic review
Srivastava, A., Kahan, M., & Ross, S. (2007) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2007.04.001 · Cited by 83
Hypothalamic-Pituitary-Adrenocortical (HPA) Axis Response and Biotransformation of Oral Naltrexone Preliminary Examination of Relationship to Family History of Alcoholism
King, A. C. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00416-x · Cited by 83
A Pilot Evaluation of the Safety and Tolerability of Repeat Dose Administration of Long‐Acting Injectable Naltrexone (Vivitrex®) in Patients With Alcohol Dependence
Johnson, B. A., Ait‐Daoud, N., Aubin, H., van den Brink, W., Guzzetta, R. V., Loewy, J. W., Silverman, B. L., & Ehrich, E. W. (2004) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000139823.30096.52 · Cited by 82
The endogenous opioid system in human alcoholics: molecular adaptations in brain areas involved in cognitive control of addiction
Bazov, I., Kononenko, O., Watanabe, H., Kuntić, V. S., Sarkisyan, D., Taqi, M. M., Hussain, M. Z., Nyberg, F., Yakovleva, T., & Bakalkin, G. Y. (2011) · Addiction Biology · doi:10.1111/j.1369-1600.2011.00366.x · Cited by 85
Pregabalin versus naltrexone in alcohol dependence: a randomised, double-blind, comparison trial
Martinotti, G., Nicola, M. D., Tedeschi, D., Andreoli, S., Reina, D., Pomponi, M., Mazza, M., Romanelli, R., Moroni, N., de Filippis, R., et al. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881109102623 · Cited by 82
Effect of acamprosate and naltrexone, alone or in combination, on ethanol consumption
Stromberg, M. F., Mackler, S. A., Volpicelli, J. R., & O’Brien, C. P. (2001) · Alcohol · doi:10.1016/s0741-8329(00)00137-3 · Cited by 81
Self-citation
Attenuation of Alcohol Consumption by a Novel Nontoxic Ibogaine Analogue (18-Methoxycoronaridine) in Alcohol-Preferring Rats
Rezvani, A. H. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)10003-x · Cited by 81
Naltrexone in the Treatment of Alcohol Dependence: A Combined Analysis of Two Trials
O’Malley, S. S., Croop, R. S., Wroblewski, J. M., Labriola, D., & Volpicelli, J. R. (1995) · Psychiatric Annals · doi:10.3928/0048-5713-19951101-11 · Cited by 81
Self-citation
Content of Dynorphins and kappa-Opioid Receptors in Distinct Brain Regions of C57BL/6 and DBA/2 Mice
Jamensky, N. T., & Gianoulakis, C. (1997) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1997.tb04476.x · Cited by 81
Substitution therapy for alcoholism: time for a reappraisal?
Chick, J., & Nutt, D. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881111408463 · Cited by 80
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Substance Use and Related Disorders, Part 1: Alcoholism
Soyka, M., Kranzler, H. R., Berglund, M., Gorelick, D. A., HESSELBROCK, V. M., Johnson, B. A., Möller, H., & THE WFSBP TASK FORCE ON TREATMENT G (2008) · The World Journal of Biological Psychiatry · doi:10.1080/15622970801896390 · Cited by 79
An overview of medications for the treatment of alcohol withdrawal and alcohol dependence with an emphasis on the use of older and newer anticonvulsants
Ait‐Daoud, N., Malcolm, R. J., & Johnson, B. A. (2006) · Addictive Behaviors · doi:10.1016/j.addbeh.2005.12.029 · Cited by 80
Pharmacotherapy of cocaine abuse: Preclinical development
Witkin, J. M. (1994) · Neuroscience & Biobehavioral Reviews · doi:10.1016/0149-7634(94)90042-6 · Cited by 80
The Effects of Naltrexone on Subjective Response to Methamphetamine in a Clinical Sample: a Double-Blind, Placebo-Controlled Laboratory Study
Ray, L. A., Bujarski, S., Courtney, K. E., Moallem, N. R., Lunny, K. F., Roche, D., Leventhal, A. M., SHOPTAW, S. J., Heinzerling, K. G., London, E. D., et al. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.83 · Cited by 79
Genetic markers of alcohol abuse
Ferguson, R. A., & Goldberg, D. M. (1997) · Clinica Chimica Acta · doi:10.1016/s0009-8981(96)06444-3 · Cited by 80

Authors: Volpicelli, J. R.
Affiliations: University of Pennsylvania (US)
Corresponding author: Volpicelli, Joseph R.
ORCID: Volpicelli, Joseph R.
Venue: Archives of General Psychiatry
Publisher: American Medical Association (AMA)
Published: 1992-11-01
Volume: 49
Issue: 11
Pages: 876
ISSN: 0003-990X (ISSN-L)
DOI: 10.1001/archpsyc.1992.01820110040006
OpenAlex: W2104538950
Cited by: 1,828
References: 23
Citations by year: 2026: 7 · 2025: 10 · 2024: 17 · 2023: 15 · 2022: 25 · 2021: 17 · 2020: 28 · 2019: 26 · 2018: 29 · 2017: 26 · 2016: 32 · 2015: 48 · 2014: 49 · 2013: 47 · 2012: 58
FWCI: 36.57
Type: journal article
Language: en
Open access: closed
Locations: Archives of General Psychiatry (publishedVersion)
PubMed (publishedVersion)
Funders: National Institute on Alcohol Abuse and Alcoholism (AA0751701A1)
National Institute on Drug Abuse (DA-05186)
Topics: Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
Health Sciences › Medicine › Clinical Neurology › Alcoholism and Thiamine Deficiency
Keywords: naltrexone, alcoholism, alcohol craving, alcohol relapse prevention, alcohol detoxification, outpatient care, opioid antagonists, adjunct pharmacotherapy, nausea, arthritic pain
MeSH terms: Adult, Alcohol Drinking, Alcoholism, Ambulatory Care, Combined Modality Therapy, Double-Blind Method, Humans, Male, Naltrexone, Nausea, Patient Dropouts, Placebos, Psychiatric Status Rating Scales, Psychotherapy, Recurrence, Severity of Illness Index, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Naltrexone in the Treatment of Alcohol Dependence

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks